These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3349458)
1. In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells. Noseda A; Berens ME; White JG; Modest EJ Cancer Res; 1988 Apr; 48(7):1788-91. PubMed ID: 3349458 [TBL] [Abstract][Full Text] [Related]
2. Tumor cell kinetics following antineoplastic ether phospholipid treatment. Principe P; Sidoti C; Braquet P Cancer Res; 1992 May; 52(9):2509-15. PubMed ID: 1568220 [TBL] [Abstract][Full Text] [Related]
3. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents. Wagner BA; Buettner GR; Burns CP Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230 [TBL] [Abstract][Full Text] [Related]
5. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide. Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine). Marino-Albernas JR; Bittman R; Peters A; Mayhew E J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506 [TBL] [Abstract][Full Text] [Related]
8. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Chabot MC; Wykle RL; Modest EJ; Daniel LW Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxic interactions of heat and an ether lipid analogue in human ovarian carcinoma cells. Fujiwara K; Modest EJ; Welander CE; Wallen CA Cancer Res; 1989 Nov; 49(22):6285-9. PubMed ID: 2804975 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells. Hoffman DR; Hoffman LH; Snyder F Cancer Res; 1986 Nov; 46(11):5803-9. PubMed ID: 3756924 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of ether-linked analogues of lysophosphatidate and their effect on the proliferation of human epithelial cancer cells in vitro. Ashagbley A; Samadder P; Bittman R; Erukulla RK; Byun HS; Arthur G Anticancer Res; 1996; 16(4A):1813-8. PubMed ID: 8712705 [TBL] [Abstract][Full Text] [Related]
12. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro. Cardile V; Mascarucci P; De Simoni MG; Jiang X; Bindoni M Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980 [TBL] [Abstract][Full Text] [Related]
13. Tumor cell kinetics following long-term treatment with antineoplastic ether phospholipids. Principe P; Sidoti C; Coulomb H; Broquet C; Braquet P Cancer Detect Prev; 1994; 18(5):393-400. PubMed ID: 7812986 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species. Wagner BA; Buettner GR; Oberley LW; Burns CP Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895 [TBL] [Abstract][Full Text] [Related]
15. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440. Petersen ES; Kelley EE; Modest EJ; Burns CP Cancer Res; 1992 Nov; 52(22):6263-9. PubMed ID: 1423272 [TBL] [Abstract][Full Text] [Related]
16. Effect of anti-tumor ether lipids on ordered domains in model membranes. Heczková B; Slotte JP FEBS Lett; 2006 May; 580(10):2471-6. PubMed ID: 16638573 [TBL] [Abstract][Full Text] [Related]
17. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220 [TBL] [Abstract][Full Text] [Related]
18. Cell kill and cytostasis by ET-18-OCH3 and heat. Fujiwara K; Modest EJ; Wallen CA Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017 [TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives. Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232 [TBL] [Abstract][Full Text] [Related]
20. Enantioselective synthesis and antiproliferative properties of an ilmofosine analog, 2'-(trimethylammonio)ethyl 3-(hexadecyloxy)-2-(methoxymethyl)propyl phosphate, on epithelial cancer cell growth. Bittman R; Byun HS; Reddy KC; Samadder P; Arthur G J Med Chem; 1997 Apr; 40(9):1391-5. PubMed ID: 9135036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]